|
|
||||||||||||||
|
|
|||||||||||||||
Review |
Kimmel Cancer Center, Thomas Jefferson University, 233 S. 10th Street, 624 BLSB, Philadelphia, PA 19107, USA
Correspondence: Dr Baserga r_baserga{at}lac.jci.tju.edu
The type 1 insulin-like growth factor receptor (IGF-IR) sends several signals, some of which are contradictory. When the concentrations of insulin receptor substrate 1 (IRS-1), a major substrate of the IGF-IR, are high, the signal is mitogenic, anti-apoptotic, and can even cause malignant transformation. However, in the absence of IRS-1, the IGF-IR sends a differentiation signal, which leads to granulocytic differentiation in haemopoietic cells. The mitogenic signal of the IGF-IR/IRS-1 combination depends largely, but not exclusively, on the activation of the phosphatidylinositol-3 kinase (PI3K).
Key Words: insulin-like growth factor 1 receptor differentiation insulin receptor substrate 1 transformation
This article has been cited by other articles:
![]() |
C. Braconi, R. Bracci, I. Bearzi, F. Bianchi, S. Sabato, A. Mandolesi, L. Belvederesi, S. Cascinu, N. Valeri, and R. Cellerino Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients Ann. Onc., July 1, 2008; 19(7): 1293 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kavurma, M. Schoppet, Y. V. Bobryshev, L. M. Khachigian, and M. R. Bennett TRAIL Stimulates Proliferation of Vascular Smooth Muscle Cells via Activation of NF-{kappa}B and Induction of Insulin-like Growth Factor-1 Receptor J. Biol. Chem., March 21, 2008; 283(12): 7754 - 7762. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ravikumar, G. Perez-Liz, L. Del Vale, D. R. Soprano, and K. J. Soprano Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid Cancer Res., October 1, 2007; 67(19): 9266 - 9275. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Frasca, G. Pandini, R. Malaguarnera, A. Mandarino, R. L. Messina, L. Sciacca, A. Belfiore, and R. Vigneri Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling J. Biol. Chem., September 7, 2007; 282(36): 26077 - 26088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yan, C.-T. Yu, M. Ozen, M. Ittmann, S. Y. Tsai, and M.-J. Tsai Steroid Receptor Coactivator-3 and Activator Protein-1 Coordinately Regulate the Transcription of Components of the Insulin-Like Growth Factor/AKT Signaling Pathway. Cancer Res., November 15, 2006; 66(22): 11039 - 11046. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Aiello, G. Pandini, F. Frasca, E. Conte, A. Murabito, A. Sacco, M. Genua, R. Vigneri, and A. Belfiore Peroxisomal Proliferator-Activated Receptor-{gamma} Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells Endocrinology, September 1, 2006; 147(9): 4463 - 4475. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Z. Michaylira, J. G. Simmons, N. M. Ramocki, B. P. Scull, K. K. McNaughton, C. R. Fuller, and P. K. Lund Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G472 - G481. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li and W. T. Miller Role of the Activation Loop Tyrosines in Regulation of the Insulin-like Growth Factor I Receptor-tyrosine Kinase J. Biol. Chem., August 18, 2006; 281(33): 23785 - 23791. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, G. Chakravarty, S. Kim, Y. D. Yazici, M. N. Younes, S. A. Jasser, A. A. Santillan, C. D. Bucana, A. K. El-Naggar, and J. N. Myers Growth-Inhibitory Effects of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) in an Orthotopic Nude Mouse Model of Anaplastic Thyroid Carcinoma Clin. Cancer Res., August 1, 2006; 12(15): 4755 - 4765. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cappuzzo, L. Toschi, G. Tallini, G. L. Ceresoli, I. Domenichini, S. Bartolini, G. Finocchiaro, E. Magrini, G. Metro, A. Cancellieri, et al. Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib Ann. Onc., July 1, 2006; 17(7): 1120 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Kellar, M. V. Lorenzi, C. P. Ho, D. You, M.-L. Wen, R. P. Ryseck, S. Oppenheimer, B. E. Fink, G. D. Vite, B. R. Rowley, et al. Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics. Mol. Cancer Ther., June 1, 2006; 5(6): 1571 - 1576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sadagurski, S. Yakar, G. Weingarten, M. Holzenberger, C. J. Rhodes, D. Breitkreutz, D. LeRoith, and E. Wertheimer Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol. Cell. Biol., April 1, 2006; 26(7): 2675 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamamoto, S. Oida, and T. Inage Gene Expression and Localization of Insulin-like Growth Factors and Their Receptors throughout Amelogenesis in Rat Incisors J. Histochem. Cytochem., February 1, 2006; 54(2): 243 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Menu, H. Jernberg-Wiklund, T. Stromberg, H. De Raeve, L. Girnita, O. Larsson, M. Axelson, K. Asosingh, K. Nilsson, B. Van Camp, et al. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model Blood, January 15, 2006; 107(2): 655 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stromberg, S. Ekman, L. Girnita, L. Y. Dimberg, O. Larsson, M. Axelson, J. Lennartsson, U. Hellman, K. Carlson, A. Osterborg, et al. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells Blood, January 15, 2006; 107(2): 669 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Decraene, R. Benchaouir, M.-A. Dillies, D. Israeli, S. Bortoli, C. Rochon, P. Rameau, A. Pitaval, D. T.-L. Roux, O. Danos, et al. Global transcriptional characterization of SP and MP cells from the myogenic C2C12 cell line: effect of FGF6 Physiol Genomics, October 17, 2005; 23(2): 132 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Osipo, K. Meeke, H. Liu, D. Cheng, S. Lim, A. Weichel, and V. C. Jordan Trastuzumab Therapy for Tamoxifen-Stimulated Endometrial Cancer Cancer Res., September 15, 2005; 65(18): 8504 - 8513. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Goel, M. Breen, J. Zhang, I. Das, S. Aznavoorian-Cheshire, N. M. Greenberg, A. Elgavish, and L. R. Languino {beta}1A Integrin Expression Is Required for Type 1 Insulin-Like Growth Factor Receptor Mitogenic and Transforming Activities and Localization to Focal Contacts Cancer Res., August 1, 2005; 65(15): 6692 - 6700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Koda, M Sulkowska, L Kanczuga-Koda, and S Sulkowski Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases J. Clin. Pathol., June 1, 2005; 58(6): 645 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Wu, A. Odman, L. M. Higgins, K. Haugk, R. Vessella, D. L. Ludwig, and S. R. Plymate In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate Tumors Clin. Cancer Res., April 15, 2005; 11(8): 3065 - 3074. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hintermann, N. Yang, D. O'Sullivan, J. M. G. Higgins, and V. Quaranta Integrin {alpha}6{beta}4-erbB2 Complex Inhibits Haptotaxis by Up-regulating E-cadherin Cell-Cell Junctions in Keratinocytes J. Biol. Chem., March 4, 2005; 280(9): 8004 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ruan, M. E. Monaco, and D. L. Kleinberg Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action Endocrinology, March 1, 2005; 146(3): 1170 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Warshamana-Greene, J. Litz, E. Buchdunger, C. Garcia-Echeverria, F. Hofmann, and G. W. Krystal The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy Clin. Cancer Res., February 15, 2005; 11(4): 1563 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bickel, J. Slade, E. Mahoney, F. Haddad, G. A. Dudley, and G. R. Adams Time course of molecular responses of human skeletal muscle to acute bouts of resistance exercise J Appl Physiol, February 1, 2005; 98(2): 482 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahlen, J. Wejde, O. Brosjo, A. von Rosen, W.-H. Weng, L. Girnita, O. Larsson, and C. Larsson Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma Clin. Cancer Res., January 1, 2005; 11(1): 206 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. McCarty Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380. [Abstract] [PDF] |
||||
![]() |
Y. Kaburagi, R. Yamashita, Y. Ito, H. Okochi, R. Yamamoto-Honda, K. Yasuda, H. Sekihara, T. Sasazuki, T. Kadowaki, and Y. Yazaki Insulin-Induced Cell Cycle Progression Is Impaired in Chinese Hamster Ovary Cells Overexpressing Insulin Receptor Substrate-3 Endocrinology, December 1, 2004; 145(12): 5862 - 5874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prieur, F. Tirode, P. Cohen, and O. Delattre EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3 Mol. Cell. Biol., August 15, 2004; 24(16): 7275 - 7283. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Goel, M. Fornaro, L. Moro, N. Teider, J. S. Rhim, M. King, and L. R. Languino Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by {beta}1 integrins J. Cell Biol., August 2, 2004; 166(3): 407 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F McCarty Insulin and IGF-I as determinants of low 'Western' cancer rates in the rural third world Int. J. Epidemiol., August 1, 2004; 33(4): 908 - 910. [Full Text] [PDF] |
||||
![]() |
T. Tsuchiya, J. M. Dhahbi, X. Cui, P. L. Mote, A. Bartke, and S. R. Spindler Additive regulation of hepatic gene expression by dwarfism and caloric restriction Physiol Genomics, May 19, 2004; 17(3): 307 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-F. Chen and M.-S. Wong Genistein Enhances Insulin-Like Growth Factor Signaling Pathway in Human Breast Cancer (MCF-7) Cells J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2351 - 2359. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Warshamana-Greene, J. Litz, E. Buchdunger, F. Hofmann, C. Garcia-Echeverria, and G. W. Krystal The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling Mol. Cancer Ther., May 1, 2004; 3(5): 527 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wessells, S. Yakar, and P. F. Johnson Critical Prosurvival Roles for C/EBP{beta} and Insulin-Like Growth Factor I in Macrophage Tumor Cells Mol. Cell. Biol., April 15, 2004; 24(8): 3238 - 3250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Stromberg, A. Dimberg, A. Hammarberg, K. Carlson, A. Osterborg, K. Nilsson, and H. Jernberg-Wiklund Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone Blood, April 15, 2004; 103(8): 3138 - 3147. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimoaka, S. Kamekura, H. Chikuda, K. Hoshi, U.-i. Chung, T. Akune, Z. Maruyama, T. Komori, M. Matsumoto, W. Ogawa, et al. Impairment of Bone Healing by Insulin Receptor Substrate-1 Deficiency J. Biol. Chem., April 9, 2004; 279(15): 15314 - 15322. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Shen, Y. Yin, S. R. Broussard, R. H. McCusker, G. G. Freund, R. Dantzer, and K. W. Kelley Tumor Necrosis Factor {alpha} Inhibits Cyclin A Expression and Retinoblastoma Hyperphosphorylation Triggered by Insulin-like Growth Factor-I Induction of New E2F-1 Synthesis J. Biol. Chem., February 27, 2004; 279(9): 7438 - 7446. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. X. Song, C. J. Barnes, Z. Zhang, Y. Bao, R. Kumar, and R. J. Santen The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor {alpha} to the plasma membrane PNAS, February 17, 2004; 101(7): 2076 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ahmad, G. Farnie, N. J. Bundred, and N. G. Anderson The Mitogenic Action of Insulin-like Growth Factor I in Normal Human Mammary Epithelial Cells Requires the Epidermal Growth Factor Receptor Tyrosine Kinase J. Biol. Chem., January 16, 2004; 279(3): 1713 - 1719. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Povsic, T. A. Kohout, and R. J. Lefkowitz {beta}-Arrestin1 Mediates Insulin-like Growth Factor 1 (IGF-1) Activation of Phosphatidylinositol 3-Kinase (PI3K) and Anti-apoptosis J. Biol. Chem., December 19, 2003; 278(51): 51334 - 51339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cunningham, Q. Zhu, T. G. Unterman, and J. M. Hammond Follicle-Stimulating Hormone Promotes Nuclear Exclusion of the Forkhead Transcription Factor FoxO1a via Phosphatidylinositol 3-Kinase in Porcine Granulosa Cells Endocrinology, December 1, 2003; 144(12): 5585 - 5594. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-D. Oh and J.-S. Chun Signaling Mechanisms Leading to the Regulation of Differentiation and Apoptosis of Articular Chondrocytes by Insulin-like Growth Factor-1 J. Biol. Chem., September 19, 2003; 278(38): 36563 - 36571. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skalkidou, E. Petridou, E. Papathoma, H. Salvanos, S. Kedikoglou, G. Chrousos, and D. Trichopoulos Determinants and Consequences of Major Insulin-like Growth Factor Components among Full-Term Healthy Neonates Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 860 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seto-Young, J. Zajac, H.-C. Liu, Z. Rosenwaks, and L. Poretsky The Role of Mitogen-Activated Protein Kinase in Insulin and Insulin-Like Growth Factor I (IGF-I) Signaling Cascades for Progesterone and IGF-Binding Protein-1 Production in Human Granulosa Cells J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3385 - 3391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wang, V. L. DeGroff, and S. K. Clinton Tomato and Soy Polyphenols Reduce Insulin-Like Growth Factor-I-Stimulated Rat Prostate Cancer Cell Proliferation and Apoptotic Resistance In Vitro via Inhibition of Intracellular Signaling Pathways Involving Tyrosine Kinase J. Nutr., July 1, 2003; 133(7): 2367 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Bickel, J. M. Slade, F. Haddad, G. R. Adams, and G. A. Dudley Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects J Appl Physiol, June 1, 2003; 94(6): 2255 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Wang, Q. Zhang, J. Wilson, M. Z. Ratajczak, and M. A. Wasik Detection of Protein Tyrosine-Kinase (PTK) Gene Expression Pattern in Normal and Malignant T Lymphocytes by Combined PTK-Specific Polymerase Chain Reaction and Parallel Denaturing Gradient Gel Electrophoresis J. Mol. Diagn., May 1, 2003; 5(2): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tang, D. Zhang, L. Fallavollita, and P. Brodt Vascular Endothelial Growth Factor C Expression and Lymph Node Metastasis Are Regulated by the Type I Insulin-like Growth Factor Receptor Cancer Res., March 15, 2003; 63(6): 1166 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fukuda, K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis, and G. L. Semenza Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells J. Biol. Chem., October 4, 2002; 277(41): 38205 - 38211. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Adams Exercise Effects on Muscle Insulin Signaling and Action: Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation J Appl Physiol, September 1, 2002; 93(3): 1159 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oldham, H. Stocker, M. Laffargue, F. Wittwer, M. Wymann, and E. Hafen The Drosophila insulin/IGF receptor controls growth and size by modulating PtdInsP3 levels Development, September 1, 2002; 129(17): 4103 - 4109. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Prisco, F. Santini, R. Baffa, M. Liu, R. Drakas, A. Wu, and R. Baserga Nuclear Translocation of Insulin Receptor Substrate-1 by the Simian Virus 40 T Antigen and the Activated Type 1 Insulin-like Growth Factor Receptor J. Biol. Chem., August 23, 2002; 277(35): 32078 - 32085. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Shen, J.-H. Zhou, S. R. Broussard, G. G. Freund, R. Dantzer, and K. W. Kelley Proinflammatory Cytokines Block Growth of Breast Cancer Cells by Impairing Signals from a Growth Factor Receptor Cancer Res., August 15, 2002; 62(16): 4746 - 4756. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tanno, A. Negroni, R. Vitali, M. C. Pirozzoli, V. Cesi, C. Mancini, B. Calabretta, and G. Raschella Expression of Insulin-like Growth Factor-binding Protein 5 in Neuroblastoma Cells Is Regulated at the Transcriptional Level by c-Myb and B-Myb via Direct and Indirect Mechanisms J. Biol. Chem., June 21, 2002; 277(26): 23172 - 23180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishii, A. Inanobe, and Y. Kurachi PIP3 inhibition of RGS protein and its reversal by Ca2+/calmodulin mediate voltage-dependent control of the G protein cycle in a cardiac K+ channel PNAS, April 2, 2002; 99(7): 4325 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Navarro, B. Valentinis, B. Belletti, G. Romano, K. Reiss, and R. Baserga Regulation of Id2 Gene Expression by the Type 1 IGF Receptor and the Insulin Receptor Substrate-1 Endocrinology, December 1, 2001; 142(12): 5149 - 5157. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishii, A. Inanobe, and Y. Kurachi PIP3 inhibition of RGS protein and its reversal by Ca2+/calmodulin mediate voltage-dependent control of the G protein cycle in a cardiac K+ channel PNAS, April 2, 2002; 99(7): 4325 - 4330. [Abstract] [Full Text] |